Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-270637
Filing Date
2020-10-16
Accepted
2020-10-16 06:04:58
Documents
2
Period of Report
2020-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d847960d6k.htm 6-K 47479
2 GRAPHIC g847960g0306042232324.jpg GRAPHIC 8035
  Complete submission text file 0001193125-20-270637.txt   59774
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 201242715
SIC: 2834 Pharmaceutical Preparations